Acid sphingomyelinase, cell membranes and human disease: Lessons from Niemann-Pick disease

FEBS Letters

Volumn 584, Issue 9, 2010, Pages 1895-1900

  Schuchman, Edward H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Ceramide; Enzyme; Lysosome; Membrane microdomain; Sphingomyelin

Indexed keywords

GANGLIOSIDE GM2; GANGLIOSIDE GM3; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SPHINGOMYELIN PHOSPHODIESTERASE;

ATHEROSCLEROSIS; ATOPIC DERMATITIS; BACTERIAL INFECTION; CELL MEMBRANE; CYSTIC FIBROSIS; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; HUMAN; LIPID BILAYER; LIPID RAFT; NIEMANN PICK DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SEMEN ABNORMALITY; SPERMATOZOON CAPACITATION; VENTILATOR ASSOCIATED PNEUMONIA; ANIMAL; DISEASE MODEL; GENERAL ASPECTS OF DISEASE; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

MUS;

ANIMALS; CELL MEMBRANE; DISEASE; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; NIEMANN-PICK DISEASES; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 77951893147     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.11.083     Document Type: Review

References (79)

1. Singer S.J., Nicolson G.L. The fluid mosaic model of the structure of cell membranes. Science. 1972, 175:720-731.
2. Jacobson K., Sheets E.D., Simson R. Revisiting the fluid mosaic model of membranes. Science 1995, 268:1441-1442.
3. Simons K., Ikonen E. Functional rafts in cell membranes. Nature 1997, 387:569-572.
4. Anderson R.G., Jacobson K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 2002, 296:1821-1825.
5. Smith E.L., Schuchman E.H. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J. 2008, 22:3419-3431.
6. Jenkins R.W., Canals D., Hannun Y.A. Roles and regulation of secretory and lysosomal acid sphingomyelinase. Cell. Signal. 2009, 21:836-846.
7. Alessenko A.V. The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation, differentiation and death. Membr. Cell Biol. 2000, 13:303-320.
8. Horinouchi K., Erlich S., Perl D.P., Ferlinz K., Bisgaier C.L., Sandhoff K., Desnick R.J., Stewart C.L., Schuchman E.H. Acid sphingomyelinase deficient mice. a model of types A and B Niemann-Pick disease. Nat. Genet. 1995, 10:288-293.
9. Thannhauser S.J., Reichel M., Grattan J.F. The effect of ascorbic acid on beta-glycerophosphate. Biochem. J. 1938, 32:1163-1165.
10. Gatt S. Enzymic hydrolysis and synthesis of ceramide. J. Biol. Chem. 1963, 238:3131-3133.
11. Levade T., Andrieu-Abadie N., Ségui B., Augé N., Chatelut M., Jaffrézou J.P., Salvayre R. Sphingomyelin-degrading pathways in human cells role in cell signalling. Chem. Phys. Lipids. 1999, 102:167-178.
12. Stoffel W. Functional analysis of acid and neutral sphingomyelinases in vitro and in vivo. Chem. Phys. Lipids 1999, 102:107-121.
13. Marchesini N., Hannun Y.A. Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem. Cell Biol. 2004, 82:27-44.
14. Schneider P.B., Kennedy E.P. Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J. Lipid Res. 1967, 8:202-209.
15. Yamanaka T., Suzuki K. Acid sphingomyelinase of human brain: purification to homogeneity. J. Neurochem. 1982, 38:1753-1764.
16. Jones C.S., Shankaran P., Callahan J.W. Purification of sphingomyelinase to apparent homogeneity by using hydrophobic chromatography. Biochem. J. 1981, 195:373-382.
17. Quintern L.E., Weitz G., Nehrkorn H., Tager J.M., Schram A.W., Sandhoff K. Acid sphingomyelinase from human urine: purification and characterization. Biochim. Biophys. Acta 1987, 922:323-336.
18. Kurth J., Stoffel W. Human placental sphingomyelinase. Purification to homogeneity, antigenic properties and partial amino-acid sequences of the enzyme. Biol. Chem. Hoppe-Seyler 1991, 372:215-223.
19. Fowler S. Lysosomal localization of sphingomyelinase in rat liver. Biochim. Biophys. Acta 1969, 191:481-484.
20. Schuchman E.H., Levran O., Pereira L.V., Desnick R.J. Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1). Genomics 1992, 12:197-205.
21. Quintern L.E., Schuchman E.H., Levran O., Suchi M., Ferlinz K., Reinke H., Sandhoff K., Desnick R.J. Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J. 1989, 8:2469-2473.
22. Pittis M.G., Ricci V., Guerci V.I., Marçais C., Ciana G., Dardis A., Gerin F., Stroppiano M., Vanier M.T., Filocamo M., Bembi B. Acid sphingomyelinase: identification of nine novel mutations among Italian Niemann Pick type B patients and characterization of in vivo functional in-frame start codon. Hum. Mutat. 2004, 24:186-187.
23. Lansmann S., Ferlinz K., Hurwitz R., Bartelsen O., Glombitza G., Sandhoff K. Purification of acid sphingomyelinase from human placenta: characterization and N-terminal sequence. FEBS Lett. 1996, 399:227-231.
24. Ferlinz K., Hurwitz R., Vielhaber G., Suzuki K., Sandhoff K. Occurrence of two molecular forms of human acid sphingomyelinase. Biochem. J. 1994, 301:855-862.
25. Ferlinz K., Hurwitz R., Moczall H., Lansmann S., Schuchman E.H., Sandhoff K. Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis. Eur. J. Biochem. 1997, 243:511-517.
26. Hurwitz R., Ferlinz K., Vielhaber G., Moczall H., Sandhoff K. Processing of human acid sphingomyelinase in normal and I-cell fibroblasts. J. Biol. Chem. 1994, 269:5440-5445.
27. Lansmann S., Schuette C.G., Bartelsen O., Hoernschemeyer J., Linke T., Weisgerber J., Sandhoff K. Human acid sphingomyelinase. Eur. J. Biochem. 2003, 270:1076-1088.
28. Qiu H., Edmunds T., Baker-Malcolm J., Karey K.P., Estes S., Schwarz C., Hughes H., Van Patten S.M. Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine. Biol. Chem. 2003, 278:32744-32752.
29. Schissel S.L., Schuchman E.H., Williams K.J., Tabas I. Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J. Biol. Chem. 1996, 271:18431-18436.
30. Schissel S.L., Keesler G.A., Schuchman E.H., Williams K.J., Tabas I. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J. Biol. Chem. 1998, 273:18250-18259.
31. Spence M.W., Byers D.M., Palmer F.B., Cook H.W. A new Zn2+-stimulated sphingomyelinase in fetal bovine serum. J. Biol. Chem. 1989, 264:5358-5363.
32. Tabas I. Secretory sphingomyelinase. Chem. Phys. Lipids 1999, 102:123-130.
33. Réthy L.A. Growth regulation, acid sphingomyelinase gene and genomic imprinting: lessons from an experiment of nature. Pathol. Oncol. Res. 2000, 6:298-300.
34. Simonaro C.M., Park J.H., Eliyahu E., Shtraizent N., McGovern M.M., Schuchman E.H. Imprinting at the SMPD1 locus: implications for acid sphingomyelinase-deficient Niemann-Pick disease. Am. J. Hum. Genet. 2006, 78:865-870.
35. Santana P., Peña L.A., Haimovitz-Friedman A., Martin S., Green D., McLoughlin M., Cordon-Cardo C., Schuchman E.H., Fuks Z., Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996, 86:189-199.
36. Lin T., Genestier L., Pinkoski M.J., Castro A., Nicholas S., Mogil R., Paris F., Fuks Z., Schuchman E.H., Kolesnick R.N., Green D.R. Role of acidic sphingomyelinase in Fas/CD95-mediated cell death. J. Biol. Chem. 2000, 275:8657-8663.
37. Llacuna L., Marí M., Garcia-Ruiz C., Fernandez-Checa J.C., Morales A. Critical role of acidic sphingomyelinase in murine hepatic ischemia-reperfusion injury. Hepatology 2006, 44:561-572.
38. Smith E.L., Schuchman E.H. Acid sphingomyelinase overexpression enhances the antineoplastic effects of irradiation in vitro and in vivo. Mol. Ther. 2008, 16:1565-1571.
39. Grammatikos G., Teichgräber V., Carpinteiro A., Trarbach T., Weller M., Hengge U.R., Gulbins E. Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy. Antioxid. Redox Signal. 2007, 9:1449-1456.
40. Zumbansen M., Stoffel W. Tumor necrosis factor alpha activates NF-kappaB in acid sphingomyelinase-deficient mouse embryonic fibroblasts. J. Biol. Chem. 1997, 272:10904-10909.
41. He X., Miranda S.R., Xiong X., Dagan A., Gatt S., Schuchman E.H. Characterization of human acid sphingomyelinase purified from the media of overexpressing Chinese hamster ovary cells. Biochim. Biophys. Acta 1999, 1432:251-264.
42. Gulbins E. Regulation of death receptor signaling and apoptosis by ceramide. Pharmacol. Res. 2003, 47:393-399.
43. Zeidan Y.H., Hannun Y.A. Activation of acid sphingomyelinase by protein kinase Cdelta-mediated phosphorylation. J. Biol. Chem. 2007, 282:11549-11561.
44. Zeidan Y.H., Wu B.X., Jenkins R.W., Obeid L.M., Hannun Y.A. A novel role for protein kinase Cdelta-mediated phosphorylation of acid sphingomyelinase in UV light-induced mitochondrial injury. FASEB J. 2008, 22:183-193.
45. Schuchman, E.H., and Desnick, R.J. (2001). Niemann-Pick disease types A and B: acid sphingomyelinase deficiencies. In The Metabolic and Molecular Bases of Inherited Disease, 8th edn. (Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D., eds; Childs, B., Kinzler, K.W., and Vogelstein, B., assoc. eds.), pp. 3589. McGraw-Hill, New York.
46. Graber D., Salvayre R., Levade T. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells. J. Neurochem. 1994, 63:1060-1068.
47. Crocker A.C. The cerebral defect in Tay-Sachs disease and Niemann-Pick disease. J. Neurochem. 1961, 17:69.
48. Brady R.O., Kanfer J.N., Mock M.B., Fredrickson D.S. The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick disease. Proc. Natl. Acad. Sci. USA 1966, 55:366-369.
49. Scandroglio F., Venkata J.K., Loberto N., Prioni S., Schuchman E.H., Chigorno V., Prinetti A., Sonnino S. Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice. J. Neurochem. 2008, 107:329-338.
50. Haberkant P., Schmitt O., Contreras F.X., Thiele C., Hanada K., Sprong H., Reinhard C., Wieland F.T., Brügger B. Protein-sphingolipid interactions within cellular membranes. J. Lipid Res. 2008, 49:251-262.
51. Sot J., Bagatolli L.A., Goñi F.M., Alonso A. Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers. Biophys. J. 2006, 90:903-914.
52. Deaglio S., Vaisitti T., Billington R., Bergui L., Omede P., Genazzani A.A., Malavasi F. CD38/CD19: a lipid raft-dependent signaling complex in human B cells. Blood 2007, 109:5390-5398.
53. van Blitterswijk W.J., van der Luit A.H., Veldman R.J., Verheij M., Borst J. Ceramide: second messenger or modulator of membrane structure and dynamics?. Biochem. J. 2003, 369:199-211.
54. Schissel S.L., Jiang X., Tweedie-Hardman J., Jeong T., Camejo E.H., Najib J., Rapp J.H., Williams K.J., Tabas I. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J. Biol. Chem. 1998, 273:2738-2746.
55. Steinert S., Lee E., Tresset G., Zhang D., Wetzel R., Hortsch R., Hebbar S., Sundram J.R., Kesavapany S., Boschke E., Kraut R. A fluorescent glycolipid-binding peptide probe traces cholesterol dependent microdomain-derived trafficking pathways. PloS One 2009, 3:e2933.
56. Galvan C., Camoletto P.G., Cristofani F., Van Veldhoven P.P., Ledesma M.D. Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase. Mol. Biol. Cell 2008, 19:509-522.
57. Bianco F., Perrotta C., Novellino L., Francolini M., Riganti L., Menna E., Saglietti L., Schuchman E.H., Furlan R., Clementi E., Matteoli M., Verderio C. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 2009, 28:1043-1054.
58. Camoletto P.G., Vara H., Morando L., Connell E., Marletto F.P., Giustetto M., Sassoè-Pognetto M., Van Veldhoven P.P., Ledesma M.D. Synaptic vesicle docking: sphingosine regulates syntaxin1 interaction with Munc18. PLoS One 2009, 4:e5310.
59. Grassmé H., Gulbins E., Brenner B., Ferlinz K., Sandhoff K., Harzer K., Lang F., Meyer T.F. Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 1997, 91:605-615.
60. Hauck C.R., Grassmé H., Bock J., Jendrossek V., Ferlinz K., Meyer T.F., Gulbins E. Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of Neisseria gonorrhoeae. FEBS Lett. 2000, 478:260-266.
61. Utermöhlen O., Karow U., Löhler J., Krönke M. Severe impairment in early host defense against Listeria monocytogenes in mice deficient in acid sphingomyelinase. J. Immunol. 2003, 170:2621-2628.
62. Esen M., Schreiner B., Jendrossek V., Lang F., Fassbender K., Grassmé H., Gulbins E. Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 2001, 6:431-439.
63. McCollister B.D., Myers J.T., Jones-Carson J., Voelker D.R., Vázquez-Torres A. Constitutive acid sphingomyelinase enhances early and late macrophage killing of Salmonella enterica serovar Typhimurium. Infect. Immun. 2007, 75:5346-5352.
64. Falcone S., Perrotta C., De Palma C., Pisconti A., Sciorati C., Capobianco A., Rovere-Querini P., Manfredi A.A., Clementi E. Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3′,5′-monophosphate pathway: key events in Escherichia coli-elicited apoptosis of dendritic cells. J. Immunol. 2004, 173:4452-4463.
65. Utermöhlen O., Herz J., Schramm M., Krönke M. Fusogenicity of membranes: the impact of acid sphingomyelinase on innate immune responses. Immunobiology 2008, 213:307-314.
66. Yu H., Zeidan Y.H., Wu B.X., Jenkins R.W., Flotte T.R., Hannun Y.A., Virella-Lowell I. Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 2009, 41:367-375.
67. Grassmé H., Jendrossek V., Riehle A., von Kürthy G., Berger J., Schwarz H., Weller M., Kolesnick R., Gulbins E. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 2003, 9:322-330.
68. Kowalski M.P., Pier G.B. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J. Immunol. 2004, 172:418-425.
69. Vanha-Perttula T., Rönkkö S., Lahtinen R. Hydrolases from bovine seminal vesicle, prostate and Cowper's gland. Andrologia 1990, 22(Suppl. 1):10-24.
70. Butler A., He X., Gordon R.E., Wu H.S., Gatt S., Schuchman E.H. Reproductive pathology and sperm physiology in acid sphingomyelinase-deficient mice. Am. J. Pathol. 2002, 161:1061-1075.
71. Morita Y., Perez G.I., Paris F., Miranda S.R., Ehleiter D., Haimovitz-Friedman A., Fuks Z., Xie Z., Reed J.C., Schuchman E.H., Kolesnick R.N., Tilly J.L. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat. Med. 2000, 6:1109-1114.
72. McGovern M.M., Pohl-Worgall T., Deckelbaum R.J., Simpson W., Mendelson D., Desnick R.J., Schuchman E.H., Wasserstein M.P. Lipid abnormalities in children with types A and B Niemann Pick disease. J. Pediatr. 2004, 145:77-81.
73. Marathe S., Kuriakose G., Williams K.J., Tabas I. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2648-2658.
74. Devlin C.M., Leventhal A.R., Kuriakose G., Schuchman E.H., Williams K.J., Tabas I. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1723-1730.
75. Jia S.J., Jin S., Zhang F., Yi F., Dewey W.L., Li P.L. Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H1743-1752.
76. Jin S., Zhang Y., Yi F., Li P.L. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 2008, 28:485-490.
77. Lampe M.A., Burlingame A.L., Whitney J., Williams M.L., Brown B.E., Roitman E., Elias P.M. Human stratum corneum lipids: characterization and regional variations. J. Lipid Res. 1983, 24:120-130.
78. Schmuth M., Man M.Q., Weber F., Gao W., Feingold K.R., Fritsch P., Elias P.M., Holleran W.M. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis. J. Invest. Dermatol. 2000, 115:459-466.
79. Jensen J.M., Fölster-Holst R., Baranowsky A., Schunck M., Winoto-Morbach S., Neumann C., Schütze S., Proksch E. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J. Invest. Dermatol. 2004, 122:1423-1431.